Where does Epigenomics AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Epigenomics AG ranks #13,972 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Epigenomics AG hold?

Epigenomics AG holds 21 US utility patents granted between 2015 and 2022, spanning 6 technology areas.

What is Epigenomics AG's Innovation Score?

Epigenomics AG has an Innovation Score of 30.0 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Epigenomics AG's patent grant rate increasing or decreasing?

Epigenomics AG's recent grant velocity is -69% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Epigenomics AG's patents?

Epigenomics AG's patents average 12.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Epigenomics AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Epigenomics AG

Q: What technology areas does Epigenomics AG focus on?

Epigenomics AG's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 21 patents, ranking #223 of 2,502 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 21 granted patents across 6 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Epigenomics ranks #13,972 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 6 technology areas.

#13,972
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.0/100): 12.3
avg claims per patent: -69%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13972 · Foreign Corporation #13,972 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,972/49,997
PHOTO-FINISH Ecole Normale…
CPC-NARROW C12Q · 6 areas
INNOV-THIN 30.0/100
CLAIMS-RICH 12.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -69% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ecole Normale Superieure De Cachan (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Epigenomics’s 30.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (36%) Velocity 3.3 pts (11%) Breadth 8.7 pts (29%) Claim depth 7.4 pts (25%)

Qualcomm Incorporated · highest

85
Abbyy InfoPoisk · near

30
Aurobindo Pharma · near

30
Epigenomics · this assignee

30
UBE Machinery · near

30
Skyhigh Networks · near

30
3D Lighting… · lowest

7

What this shows Epigenomics's Innovation Score is 30.0/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Epigenomics?

Each dot is one of Epigenomics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Epigenomics’s own 12.3 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Epigenomics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Epigenomics's grants concentrate

Epigenomics AG is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2016. By volume, Epigenomics sits between Eldor Corporation S.P.A. and Ecole Normale Superieure De Cachan.

Epigenomics's three-year grant acceleration

Epigenomics AG shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Eldor S P A

21
Emcore

21
Emergency Alert S…

21
Empi

21
Erae AMS

21
Ewald DÖRKEN

21
Exela Pharma Scie…

21
Ecole Normale Sup…

21
Epigenomics ◀

21

What this shows Epigenomics holds 21 patents at rank #13,962, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Epigenomics

By rank, the assignees closest to #13,962 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Epigenomics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Epigenomics, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Epigenomics ranks #223 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

Aurobindo Pharma Ltd 30 UBE Machinery Corporation, Ltd. 30 Skyhigh Networks, LLC 30 Abbyy InfoPoisk LLC 30

Epigenomics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Epigenomics AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	14.3%
2016	1	4.8%
2017	6	28.6%
2018	5	23.8%
2019	1	4.8%
2020	2	9.5%
2021	1	4.8%
2022	2	9.5%

Which technologies does Epigenomics AG patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 21

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

Y10T - Technical Subjects Covered BY Former US Classification 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Epigenomics AG's patent record in context - here's where to go next.

Epigenomics AG's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #13,972 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Epigenomics AG against Eldor Corporation S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.